Yanet Elias, MBA
About Yanet Elias, MBA
Yanet Elias, MBA, is a Cell Therapy Account Specialist at Kite Pharma, where she has worked since 2017. She specializes in building strategic relationships in the oncology sector and has contributed to the launch of Yescarta, the first CAR T therapy approved for DLBCL in adults.
Work at Kite Pharma
Yanet Elias has been employed at Kite Pharma since 2017, serving as a Cell Therapy Account Specialist. In this role, she operates within the Miami/Fort Lauderdale area and focuses on the oncology sector. Her responsibilities include developing and maintaining strategic relationships with academic institutions, advocacy groups, and medical directors. This position allows her to leverage her expertise in cell therapy and oncology to drive business growth and improve patient outcomes.
Education and Expertise
Yanet Elias holds a Bachelor of Business Administration (B.B.A.) with a focus on Management Information Systems and Marketing from Florida International University, where she studied from 1991 to 1992. She furthered her education at the University of Miami Herbert Business School, earning an Executive MBA in Health Administration from 1998 to 1999. Her educational background equips her with a strong foundation in business management and health administration, which she applies in her current role.
Background
Yanet Elias has a background in oncology business trends, with a strong ability to anticipate and capitalize on emerging developments in the field. Her experience includes a focus on strategic relationship management, particularly with academic teaching institutions and medical professionals. This background supports her work in the cell therapy sector, where she plays a critical role in promoting innovative therapies.
Achievements
Yanet Elias played a significant role in the launch and promotion of Yescarta, the first CAR T therapy approved for diffuse large B-cell lymphoma (DLBCL) in adults. Her contributions to this initiative highlight her expertise in oncology and her ability to navigate complex market dynamics. Additionally, she is recognized for optimizing operations and streamlining processes, which have led to improved revenue results and enhanced operational efficiency.